Risk of amblyopia recurrence after cessation of treatment.
Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, Cotter SA, Donahue S, Everett DF, Hertle RW, Keech RV, Paysse E, Quinn GF, Repka MX, Scheiman MM; Pediatric Eye Disease Investigator Group.
Holmes JM, et al. Among authors: keech rv.
J AAPOS. 2004 Oct;8(5):420-8. doi: 10.1016/S1091853104001612.
J AAPOS. 2004.
PMID: 15492733
Clinical Trial.